Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘SEBI Listing Regulations’) Sequent Scientific has informed Sharat Pandurang Narasapur, Jt. Managing Director has through his letter dated April 03, 2024 has tendered his resignation from the employment of the Group for personal reasons. Consequently, Sharat Pandurang Narasapur has resigned as a Jt. Managing Director (MD) from the Board of Directors of the Company, with effect from the close of business hours on April 30, 2024. Pursuant to the above, Sharat Pandurang Narasapur shall cease to be a Member of the Corporate Social Responsibility Committee of the Board effective close of business hours on April 30, 2024. However, he shall continue as a Director (Nonexecutive) in the Board of the wholly owned subsidiary Alivira Animal Health. Further, the information required in terms of Regulation 30 read with Schedule III – Para A (7) of Part A of the SEBI Listing Regulations and SEBI Master Circular bearing Ref. No. SEBI/HO/CFD/ PoD2/CIR/P/2023/120 dated July 11, 2023 is enclosed as ‘Annexure-I’ to this letter. The company has attached the letter of resignation received from Sharat Pandurang Narasapur.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1486.55 |
Dr. Reddys Lab | 5860.25 |
Cipla | 1482.55 |
Zydus Lifesciences | 1072.35 |
Lupin | 1613.65 |
View more.. |